Spots Global Cancer Trial Database for Safety and Efficacy of Firmagon® (Degarelix) for Injection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Efficacy of Firmagon® (Degarelix) for Injection
Official Title: Post-Marketing Surveillance to Evaluate the Safety and Efficacy of Firmagon® (Degarelix) for Injection
Study ID: NCT02886598
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the safety and efficacy of Firmagon® (degarelix) for injection under the conditions of general clinical practice in Korea.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Gangnam Severance Hospital (there may be other sites in this country), Seoul, , Korea, Republic of
Contact Details
Name: Global Clinical Compliance
Affiliation: Ferring Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
